“a favorable trend”

7 ). While in subgroup (MI vs CLW), there was a statistically significant difference with a favorable trend in the MI technique ( P = 0.00 < 0.05) (Fig. 8 ).

The WIZARD (Weekly Intervention with Zithromax for Atherosclerosis and its Related Disorders) study failed to find a long-term benefit, even though a favorable trend was noted during and shortly after 3 months of azithromycin treatment. 12 More recent trials, ACES (Azithromycin and Coronary Events Study) 13 and PROVE IT-TIMI 22 (Pravastatin Or Atorvastatin Evaluation and Infection Therapy), 14 also reported a negative outcome.

Unpublished results ( http://10.0.82.211/rs.3.rs-2451089/v1 Peili Bu) showed that TXL led to a decrease in fibrous cap thickness increase by 27.42 μm compared with the control group, improvement in lipid core angle, reduction in severity grading of angina pectoris, and improvement in quality of life (measured by using Seattle Angina Questionnaire score), showing a favorable trend in reducing composite endpoint events (eg, all-cause death, nonfatal MI, stroke, hospitalization due to angina pectoris).

8.5 months, suggesting a favorable trend. 286 These results indicate that stroma-directed therapies may require biomarker-based patient selection, and that patients with high hyaluronan levels are more likely to experience clinical benefit from improved drug delivery.

In our investigation, a favorable trend in DCR was observed.

Although exercise adherence showed a favorable trend (OR = 1.49), the difference did not reach statistical significance, likely due to limited sample size and relatively short intervention duration.

These results suggest a favorable trend in CV outcomes consistent with studies of injectable semaglutides.

Promising numerical differences were observed, including a higher proportion of patients achieving functional independence (mRS 0–1 at 90 days) and a favorable trend in the 90-day ordinal shift analysis.

Conclusions In a real‐world national cohort of patients with HFpEF, spironolactone use reduced all‐cause death and demonstrated a favorable trend in reducing the burden of hospitalizations. heart failure with preserved ejection fraction mineralocorticoid antagonism outcomes real‐world studies spironolactone Subject Categories Heart Failure HFpEF patients in our cohort were 96% men, 85% White, and an average age of 74±11 years old at the beginning of follow‐up.

Despite a favorable trend of increased SLNB (14.9 to 54.2%) with decreased ALND (29.5 to 9.1%) over the time frame of our study, practice patterns nevertheless do not adhere to NCCN and ASCO guidelines regarding axillary evaluation, and demonstrate variation by patient ages, tumor size, geographic location, and practice facility type.

Furthermore, the integrated analysis demonstrated a favorable trend towards ceftaroline improving clinical cure rates reaching statistical significance.

Among patients reconstructed with gingivobuccal flaps (n = 18), 16/18 (88.9%) maintained stable tip projection, suggesting a favorable trend but not demonstrating superiority.

Furthermore, we confirmed that ZKSCAN3 mRNA expression is inversely correlated with the prognosis of PaCa patients, meaning that strong expression of ZKSCAN3 in PaCa patients is associated with extended OS and a favorable trend in RFS.

Regarding prognostic impact, our data show a favorable trend in overall survival for patients who received targeted therapies guided by ctDNA results.

6 L, the RS determined by our model roughly demonstrated a favorable trend toward an immunotherapy response.

The addition of durvalumab without olaparib (DBC) showed a favorable trend toward improved survival, albeit without statistical significance [ 9 ].

Although fasting insulin did not change significantly, the 27.9% reduction in HOMA-IR in the combined group indicates a favorable trend toward enhanced insulin sensitivity, which may become significant in longer trials or larger cohorts.

Conclusion This meta-analysis provides preliminary evidence that Traditional Chinese Medicine (TCM) may effectively improve major symptoms associated with post-COVID-19 syndrome, particularly chest tightness and insomnia, while also demonstrating a favorable trend toward alleviating fatigue and dyspnea.

Although one-way ANOVA with post-hoc analysis revealed no statistically significant differences across groups ( p > 0.05), this condition consistently exhibited a favorable trend.

While healthcare professionals over 50 years old show a favorable trend (OR = 2.291), and women appear to adopt the tool more readily than men, these associations are not statistically significant (see Table 7 ).

There was a favorable trend in these subgroups, however, as the ASD patients had a mean improvement of 20% and the scoliosis patients had a mean improvement of 53% Functional status also showed significant improvement, with a mean pre-operative ODI score of 44.5 improving to 21.8 ( p <0.001) postoperatively, representing a 51% improvement.

7.77%; HR 0.25; 0.07–0.85; p = 0.05) (although it is at the threshold, there is a favorable trend).

On the other hand, Figure 1 shows that annual cerebrovascular mortality rates in Brazilian capitals had a favorable trend to decline for all genders and age groups, despite patterns variability across the regions in the country ( Table 2 ).

The pooled HRs of analysis of among women with either HER-2 positive or HER-2 negative status showed a favorable trend but no statistical difference between the 2 treatment arms.

The first interim analysis, at a median follow-up of 17.9 months, showed a statistically significant improvement in PFS (24-month PFS was 67.8% with pembrolizumab + CCRT versus 57.3% with placebo + CCRT) and a favorable trend in OS (HR = 0.73) for the combination pembrolizumab and CCRT compared with placebo and CCRT, with a manageable safety profile.